The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP) in China:Prevalence, Risk Factors, Complications, Pregnancy and Perinatal Outcomes by Ye, Chun et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP)
in China
Citation for published version:
Ye, C, Ruan, Y, Zou, L, Li, C, Chen, Y, Jia, C, Megson, IL & Zhang, W 2014, 'The 2011 Survey on
Hypertensive Disorders of Pregnancy (HDP) in China: Prevalence, Risk Factors, Complications, Pregnancy
and Perinatal Outcomes' PLoS One, vol. 9, no. 6, e100180. DOI: 10.1371/journal.pone.0100180
Digital Object Identifier (DOI):
10.1371/journal.pone.0100180
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS One
Publisher Rights Statement:
Copyright:  2014 Ye et al. This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
The 2011 Survey on Hypertensive Disorders of
Pregnancy (HDP) in China: Prevalence, Risk Factors,
Complications, Pregnancy and Perinatal Outcomes
Chun Ye1, Yan Ruan1, Liying Zou1, Guanghui Li1, Changdong Li1, Yi Chen1, Chaoxia Jia2, Ian L. Megson3,
Jun Wei3, Weiyuan Zhang1*
1Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China, 2Department of public healthcare information
administrative section, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China, 3Department of Diabetes & Cardiovascular Science,
University of the Highlands & Islands, Inverness, United Kingdom
Abstract
Hypertensive disorders of pregnancy (HDP) are a group of medical complications in pregnancy and also a risk factor for
severe pregnancy outcomes, but it lacks a large-scale epidemiological investigation in recent years. This survey represents a
multicenter cross-sectional retrospective study to estimate the prevalence and analyze the risk factors for HDP among the
pregnant women who had referred for delivery between January 1st 2011 and December 31st 2011 in China Mainland. A
total of 112,386 pregnant women were investigated from 38 secondary and tertiary specialized or general hospitals
randomly selected across the country, of which 5,869 had HDP, accounting for 5.22% of all pregnancies. There were
significant differences in the prevalence of HDP between geographical regions, in which the North China showed the
highest (7.44%) and Central China showed the lowest (1.23%). Of six subtypes of HDP, severe preeclampsia accounted for
39.96%, gestational hypertension for 31.40%, mild preeclampsia for 15.13%, chronic hypertension in pregnancy for 6.00%,
preeclampsia superimposed on chronic hypertension for 3.68% and eclampsia for 0.89%. A number of risk factors for HDP
were identified, including twin pregnancy, age of .35 years, overweight and obesity, primipara, history of hypertension as
well as family history of hypertension and diabetes. The prevalence of pre-term birth, placental abruption and postpartum
hemorrhage were significantly higher in women with HDP than those without HDP. The possible risk factors confirmed in
this study may be useful for the development of early diagnosis and appropriate treatment of HDP.
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Introduction
Hypertensive disorders of pregnancy (HDP) are a group of
common medical complications in pregnancy, and also a major
cause of maternal and neonatal mortality and morbidity [1]. The
prevalence of HDP is 8–10% of all pregnancies in the population
worldwide [2]. It can develop during pregnancy or delivery, and
its clinical presentation is characterized by hypertension, protein-
uria and edema. HDP can also trigger some severe forms of
maternal complications, such as cardiovascular and cerebrovas-
cular diseases, liver and kidney failure, placental abruption,
disseminated intravascular coagulation (DIC) and HELLP syn-
drome. Under these circumstances, the placenta dysfunction may
occur, leading to fetal growth restriction, fetal distress, preterm
birth, intrauterine fetal demise, stillbirth and neonatal asphyxia.
While HDP has been described as a maternal complications over
the last several decades [3], its true etiology and pathophysiology
remains unknown; HDP-related complications are still threatening
maternal and fetal life and health. The prognosis of HDP is
associated with the severity of disease process. In general, the more
severe the disease is, the poorer prognosis is. Despite a massive
research effort, there was also lack of efficient therapeutic methods
in clinic at present. For the unpredictable characteristic and
potential poor prognosis, symptomatic treatment to relieve clinical
symptoms and timely termination of pregnancy were the main
treatment measures, which can effectively increase curative rate
and decrease complication rate and mortality.
Over the past few decades, relevant literatures about HDP have
been focused on a small sample of individual hospitals or a single
complication, lacking of large-scale samples with multi-variables
research. Such previous works were not sufficient to provide
detailed information for the current situation of HDP. Accord-
ingly, our study was designed to perform a comprehensive
retrospective survey with a large-scale sample collected at 38
hospitals across 14 provinces and regions in China mainland. The
aims of this survey were to analyze the prevalence and possible risk
factors of HDP, to investigate the effect of HDP and HDP related
complications on maternal and perinatal outcomes.
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Methods
Study Population
Thirty-eight general or maternity hospitals were randomly
selected from 14 provinces and regions over the country (except
Hong Kong and Macau), covering the secondary and tertiary
hospitals. As shown in Figure 1, these 14 provinces and regions
located in seven territories of mainland China, including North
China, Northeast China, Northwest China, East China, Southwest
China, South China and Central China. In mainland China, a
level 3A hospital is the highest level of care and a level 2A gives
middle level of care. A total of 112,386 pregnant women, who
gave birth between January 1st 2011 and December 31st 2011,
were investigated. This study was approved by the Ethics
Committees of medical institutions involved and conformed to
the guidelines of the Helsinki agreement and its amendments. The
National Research Ethics Service had previously approved the
anonymous use of these data for research purposes, and hence,
individual informed consent was not required. Clinical informa-
tion stored in an electronic format was collected retrospectively
from all the patients by reviewing their clinical medical recording
files, not by face-to face or direct telephone calls.
A research database was retrospectively constructed with
information regarding the maternal demographic data, reproduc-
tive history, family history, characteristics of pregnancy and
delivery in the period between the first antenatal visit and
postpartum. All information was collected on the basis of
standardized antenatal, obstetric and neonatal records.
Selection Criteria
The diagnosis of HDP was made based on its occurrence in the
period between antepartum and postpartum. According to the
latest version of classification system by the National High Blood
Pressure Education Program (NHBPEP) Working Group, HDP
was categorized into six subtypes, which include: gestational
hypertension (GH), mild preeclampsia, severe preeclampsia,
eclampsia, preeclampsia superimposed on chronic hypertension
(PSCH) and chronic hypertension in pregnancy (CHP) [4]. GH is
defined as a systolic blood pressure (SBP) of $140 mmHg and/or
diastolic blood pressure (DBP) of $90 mmHg without proteinuria,
which developed after 20 weeks of gestation and returned to
normal within 12 weeks of postpartum. Mild preeclampsia is
defined by the minimum criteria of blood pressure $140/
90 mmHg after 20 weeks of gestation and proteinuria of $
300 mg in a 24-hour urine specimen or 1+ in two random urine
samples collected at least 4 hours apart. Severe preeclampsia is
diagnosed if there are more severe elevations of blood pressure or
evidence of other end-organ dysfunction. Preeclampsia is consid-
Figure 1. The prevalence of HDP in China during 2011.
doi:10.1371/journal.pone.0100180.g001
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ered severe if one or more of the following criteria is present as
follows (ACOG, 2002) [5]: (1) systolic blood pressure (SBP) of $
160 mmHg and/or diastolic blood pressure (DBP) of $
110 mmHg; (2)Proteinuria of $5 g in 24-hour urine or $3+ in
two random urine samples collected at least 4 hours apart; (3)
Oliguria of less than 500 ml in 24 hours; (4) Cerebral or visual
disturbances; (5) Pulmonary edema or cyanosis; (6) Epigastric or
right upper-quadrant pain; (7) Impaired liver function; (8)
Thrombocytopenia(platelet counts ,100,000/mm3); (9) Fetal
growth restriction.
Eclampsia is the occurrence of a seizure in women in association
with preeclampsia, in the absence of any other cause for seizures.
PSCH is defined as the new establishment of proteinuria of $
300 mg in 24 h urine in women of chronic hypertension which
before 20 weeks of gestation but without proteinuria, or women of
chronic hypertension with proteinuria before 20 weeks of gestation
but appeared in urine protein or a sudden increase in blood
pressure or platelet counts ,100,000/mm3. CHP is defined as
blood pressure of $140/90 mmHg before pregnancy or diag-
nosed prior to 20 weeks of gestation, or developed hypertension
after 20 weeks of gestation and continued for 12 weeks of
postpartum. It is very important to differentiate these 6 subtypes of
HDP in determining prognosis and management [6].
The following factors were used as variables associated with risk
of HDP in the present study: (1) body mass index (BMI) is
calculated by weight in kilograms divided by (height in meters
squared), in which BMI of 24.0–27.9 kg/m2 is defined as
overweight and $28 kg/m2 as obese in Chinese population(in
this study, we study the pre-pregnancy BMI) [7]; (2) preterm birth
is defined as that occurring after 20 weeks and before 37
completed weeks of gestation internationally. This study used the
Chinese standard (between 28 and 37 weeks of gestation); (3)
neonatal asphyxia is defined as a hypoxia status, in which the baby
only had a heartbeat but failed to breath at all or failed to establish
regular breathing with a minute after fetal delivery (an Apgar score
of less than 7 at 5 minutes after birth). (4) Fetuses and neonates
who were born dead, or died in the first 28 days after delivery,
were considered as perinatal dealth. (5) Neonates who were born
with birth weights lower than 2500 g were considered as low birth
weight (LBW) [6]. (6) Maternal complications are some conditions
secondary to HDP, such as placental abruption, heart failure,
renal failure, DIC, HELLP syndrome and cerebral vascular
accident. We use the International Classification of Diseases (ICD-
10) codes according to the hospital medical recording files to
identity women who had complications.
We first examined the maternal characteristics of study subjects
with HDP and then constructed a research database with the
following information: (1) general information including maternal
age (stratified as under the age of 20, 20–24, 25–29, 30–34, 35–39,
40 years and older), pre-pregnancy BMI, basal blood pressure that
was measured at the first antenatal visit in first trimester or not
(including basal SBP, basal DBP), ABO blood types, smoking,
drinking and education; (2) reproductive history of pregnancies
including gravidity, parity, number of abortions, history of
stillbirths and HDP; (3) family history of hypertension and type-
2 diabetes mellitus (T2DM) in parents of pregnant women; (4)
clinical data including anemia, gestational DM (GDM) or T2DM,
onset season, paternal age (stratified as under the age of 35, 35
years and older),singleton or twin pregnancies, fertilization
method, modes of deliveries, sex of infants, birth weight, Apgar
score, live birth and stillbirths; (5) maternal complications as
mentioned above.
Statistical Analyses
All data were inputted into computer for statistical analysis.
Statistical analyses were performed using Microsoft Excel 2010
and SPSS version18.0. U test or x2 test was used to compare
frequencies among the categorical data. The risk factors identified
were encoded as independent variables (Table S1 in File S1).
Logistic regression models were used to identify the potential risk
factors that might be associated with HDP, with calculation of
odds ratios (OR) with 95% confidence intervals (CI). The model
parameters were estimated by a maximum likelihood ratio test,
which maximizes the likelihood of the observed data through
several detections. Using univariate regression analysis to conduct
the preliminary screening, a total of 23 independent variables were
identified and selected for analysis, some of which were confirmed
as the major factors associated with HDP. Multivariable logistic
regression analysis was performed to determine the independent
risk factors for the development of HDP using selected parameters
with a P-value of ,0.05 that was obtained from univariate
regression analysis. When the occurrence of outcome was low (,
10%), we assumed that the OR was equal to the relative risk. The
risk factors with an OR value of .1.5 were defined as a major risk
factor for HDP. All statistical tests and the value were two-sided,
and the limit of statistical significance was P,0.05.
Quality Assurance
All the subjects were interviewed with a questionnaire by
specially trained professional person in a standardized way.
Building an investigating collaborative group in collaboration
with the person in charge of the assisted hospitals, to check out
each questionnaire, and carry out random sampling and result to
determine. Data were collected and recorded by specially trained
medical staff (obstetrics and gynecology doctors and students) and
randomly cross-checked by designated staff (high qualification
doctors of obstetrics and gynecology). Statistical analysis was under
the guidance and supervision of a professional statistician, so as to
ensure the accuracy of the analysis results.
Results
Of the 112,386 pregnant women whose information was
sampled, of which 5869 (5.22%) were identified with HDP, while
the rest of 106517 with normotensive as the control group. Among
them, 91171 were primipara and 21215 were multipara (Table 1).
Among the patients with HDP, 78.99% were 20–34 years old
(29.9366.38 years old), 75.99% experienced their first parity, and
in 90.69%, hypertension were diagnosed in the third trimester of
pregnancy or 12 weeks after delivery (34.8465.46 weeks).
The Prevalence of HDP in China
A total of 112,386 pregnant women were recorded within the
study period and their demographic characteristics were given in
Table 1. Among the study population, 5,869 developed HDP
(5.22% of all deliveries during 2011), of whom 2,016 (31.40%)
were diagnosed as having GH, 888 (15.13%) as having mild
preeclampsia, 2345 (39.96%) as having severe preeclampsia, 52
(0.89%) as having eclampsia, 216 (3.68%) as having PSCH and
352 (6.00%) as having CHP. Of the 112,386 pregnant women
whose information was sampled, of which 5869 (5.22%) were
identified with HDP, while the rest of 106517 with normotensive
as the control group.(Figure 1).
The Possible Risk Factors for HDP
For HDP as dependent variable Y (Yes = 1, No= 0) and various
factors as independent variables, logistic regression models were
Hypertensive Disorders of Pregnancy in China
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constructed to analysis these interactions. (Table S1 in File S1). A
total of 23 independent variables were selected for analysis, 18 of
which were confirmed to be possible risk factors by univariate
regression analysis of individual variables (Table 2). The factors
which had an effect size of OR .1.5 (P,0.001) included twin
pregnancy (OR=3.68, 95%CI 3.26,4.16), alcohol consumption
(OR=1.75, 95%CI 1.45,2.11), family histories of hypertension
(OR=3.17, 95%CI 2. 71,3.71) and T2DM (OR=2.67, 95%CI
2. 07,3.44), high basal SBP($70 mmHg) (OR=2.81, 95%CI
2.66,2.97), alcohol consumption (OR=1.75, 95%CI 1.45,2.11),
high basal DBP ($120 mmHg)(OR=1.67, 95%CI 1.59,1.77)
and GDM (OR=2.48, 95%CI 2. 28,2.69).
Although co-linearity diagnostics with these 18 HDP-underlying
factors failed to show co-linearity between these variables (Table
S2 in File S1), multivariate logistic regression analysis identified
some additional risk factors with an OR of .1.5 (Table S3 in File
S1). Pregnant women aged 25–29 years had the lowest risk of
HDP (the prevalence of 4.33%) compared with those aged 35–39
years (9.42%, adjusted OR=1.84, 95%CI 1.62,2.09, P,0.001)
and those aged 40 years and older(12.73%, adjusted OR=2.39,
95%CI 1.86,2.91, P,0.001). Compared with women who had a
normal pre-pregnancy BMI, the risk of HDP was 1.8 times higher
in those who were overweight (adjusted OR=1.79, 95%CI
1.63,1.96, P,0.001) and 3.1 times higher in those obese
(adjusted OR=3.11, 95%CI 2.71,3.56, P,0.001). Multiparous
women had a lower risk of HDP than those who were primipara
(adjusted OR=0.66, 95%CI 0.58,0.76, P,0.001). Both parity
and history of abortion appeared to make further contribution to
the development of HDP: with women who had .3 parities being
more likely to develop HDP than those who had one previous
childbirth (adjusted OR=2.05, 95%CI 1.18,3.56, P,0.001), and
women who had history of abortion was also at a higher risk of
HDP (Table S3 in File S1). The prevalence of pre-term birth,
placental abruption, postpartum hemorrhage and caesarean
delivery rate were significantly higher in women with HDP than
those without HDP (Table 3). It was also found that there was also
a significant difference between the six subtypes of HDP. The
incidence rates of adverse pregnancy outcomes in eclampsia,
severe preeclampsia and PSCH group were significant higher than
that in patients with GH and normal pregnancy group (Table S4
in File S1).
Table 1. Demographic characteristics of the 112,386 pregnant women in the study.
All subjects Constituent Ratio % Subjects with HDP
N % Constituent Ratio %
Age (years) ,20 1528 1.36 78 5.10 1.33
20–24 24260 21.59 1064 4.39 18.13
25–29 46882 41.72 2028 4.33 34.55
30–34 27628 24.58 1544 5.59 26.31
35–39 9253 8.23 872 9.42 14.86
$40 1979 1.76 252 12.73 4.29
Unknown 856 0.76 31 3.62 0.53
Pre-pregnancy BMI (kg/m2) ,24.0 53957 48.01 2165 3.81 36.89
24.0, 9646 8.58 824 8.54 14.04
$28.0 2367 2.11 400 16.90 6.81
Unknown 46416 41.30 2480 5.34 42.26
Gravidity 1 56828 50.57 2656 4.67 45.25
2 30721 27.34 1603 5.22 27.31
$3 24837 22.10 1610 6.48 27.43
Parity 1 91171 81.12 4460 4.89 75.99
2 19075 16.97 1209 6.34 20.60
3 1923 1.71 177 9.20 3.02
$4 217 0.19 23 10.60 0.39
Abortion 0 69593 61.92 3328 4.78 56.70
1 26509 23.59 1506 5.68 25.66
2 11137 9.91 694 6.23 11.82
$3 5147 4.58 341 6.63 5.81
Education level Above university 55586 49.46 2715 4.88 46.26
Secondary school 30000 26.69 1579 5.26 26.90
Primary school 22531 20.05 1301 5.77 22.17
Illiteracy 260 0.23 23 8.85 0.39
Unknown 4009 3.57 251 6.26 4.28
Pregnancy Singleton 110385 98.22 5543 5.02 94.44
Twin 2001 1.78 326 16.29 5.56
doi:10.1371/journal.pone.0100180.t001
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The HDP-related Complications
As shown in Table 4, the prevalence of low birth weight(LBW,
,2500 g), neonatal asphyxia and perinatal deaths were signifi-
cantly higher in women with HDP than in those without HDP
(P,0.001). Among 5,869 women with HDP, 4,516 (76.95%) had
cesarean sections (CS). The CS rate in women with HDP was
significantly higher than those without HDP (53.36%), with an
OR of 2.92 and 95% CI 2.74,3.10 (X2= 1248.7, P,0.001).
The prevalence of severe pregnancy complications varied
among women with HDP: placental abruption showed the highest
(3.20%) and DIC showed the lowest(0.12%) (Table 5).
Of 5,869 women with HDP, 5 died and the causes of maternal
death were functional failures of the main organs (heart, lung and
kidney, 3 cases), severe pulmonary hypertension associated with
HELLP syndrome (1 case), the rest cause of death was unknown.
Of these 5 maternal deaths, 3 occurred in patients with severe
preeclampsia. By contrast, among 106,517 women without HDP,
8 died and the main causes of maternal deaths were amniotic fluid
embolism, DIC and heart failure.
Discussion
The present study revealed that the 5.22% prevalence of HDP
in the Chinese female population in 2011 was lower than that
reported in other populations, such as African Americans (6.4%),
and Brazilians (7.5%) [8–9]. This variation between populations
may be attributed to the differences in ethnic background, age
distribution, socio-economic status, and the number of times of
gravidity and parity. It is worth noting that the 1988 survey on
HDP reported a prevalence of 9.4% in China [10], while this 2011
nationwide study suggests that the prevalence of HDP has come
down in recent years in the Chinese population. It may be
attributed to the fact that sampling was performed from different
geographical areas in China. We found that, there is a large
difference in the prevalence of HDP between geographical regions
across the country (Figure 1). This may be associated with the
rapid development of the economy in China, which could facilitate
an improvement in living standards, education level, medication
and health care, such as the improvement of HDP prediction
technology and precautionary measures. While imbalanced
development of regional economy and socio-demographic differ-
ences are the most likely reasons in China, different climate and
weather may also contribute to an increased risk of HDP. Some
Table 3. Differences in pregnancy outcomes between women with and without HDP.
Group N Preterm Birth (%)
Placental
Abruption (%)
Postpartum
Hemorrhage (%)
Cesarean
Section (%)
GH 2016 227(11.26) 16(0.79) 143(7.09) 1327(65.82)
Mild Preeclampsia 888 128(14.41) 19(2.14) 58(6.53) 695(78.27)
Severe Preeclampsia 2345 1166(49.72) 129(5.50) 132(5.63) 2023(86.27)
Eclampsia 52 37 (71.15) 6(11.54) 1(1.92) 49(94.23)
PSCH 216 113(52.31) 14(6.48) 13(6.02) 176(81.48)
CHP 352 52(14.77) 4(1.14) 31(8.81) 246(69.89)
With HDP 5869 1723(29.36) 188(3.20) 378(6.44) 4516(76.95)
Without HDP 106517 7226(6.78) 452(0.42) 3821(3.59) 56834(53.36)
Total 112386 8949(7.96) 640(0.57) 4199(3.74) 61350(54.59)
X2 3867.7 758.6 125.9 1248.698
P ,0.001 ,0.001 ,0.001 ,0.001
doi:10.1371/journal.pone.0100180.t003
Table 4. Differences in perinatal outcomes between women with and without HDP.
Group N LBW (%) Neonatal Asphyxia (%) Perinatal Death (%)
GH 2091 214(10.23) 102(4.88) 44(2.10)
Mild Preeclampsia 949 159(16.75) 58(6.11) 11(1.16)
Severe Preeclampsia 2522 1134(44.96) 479(18.99) 206(8.17)
Eclampsia 53 40(75.47) 24(45.28) 5(9.43)
PSCH 222 93(41.89) 66(29.73) 31(13.96)
CHP 358 40(11.17) 31(8.66) 17(4.75)
With HDP 6195 1697(27.39) 760(12.27) 314(5.07)
Without HDP 108192 6167(5.70) 3689(3.41) 1456(1.35)
Total 114387 7864(6.87) 4449(3.89) 1770(1.55)
X2 4306.9 1230.0 533.1
P ,0.001 ,0.001 ,0.001
doi:10.1371/journal.pone.0100180.t004
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data tend to suggest that eclampsia is associated with cooler
temperatures or winter or with increased humidity or rainfall [11–
12]. The exact mechanism is beyond the scope of our study.
Further investigation is needed to confirm whether a low
temperature-induced vasoconstriction may trigger an onset of
HDP, leading to the highest prevalence of the condition in this
region. The Northern China has a colder climate and longer
winter time as compared to other regions. It still needs further
study.
Apart from the environmental factors, individual background in
genetics and medical history are factors that influence the
development of HDP. The risk of HDP was 1.75 times in alcohol
consumers comparing with no alcohol consumers. Epidemiological
studies have demonstrated a close association between alcohol use
and an increased risk of hypertension [13–15], but few studies
have directly addressed the role of drinking pattern. In our study,
hypertension has no obvious relationship with cigarette smoking.
Paradoxically, Studies have shown that smoking during pregnancy
has been associated with a reduced risk of preeclampsia [16]. For
example, smoking during pregnancy reduces the risk of pre-
eclampsia by up to 50% with a dose-response pattern [17].
Numerous studies have shown that twin pregnancy is an important
risk factor for HDP. Our study suggested that 16.29% of 2001
women with a twin pregnancy developed HDP as compared with
5.02% of 110,385 women with a single pregnancy (Table 1). This
result strongly supports previous reports indicating that the risk of
HDP in women with a twin pregnancy was 2 or 3 times higher
than those with a single pregnancy [18–20]. Numbers of studies
indicate that the prevalence of HDP increases with maternal age
[19], [21–22]. For an example, the risk of preeclampsia has been
shown to increase by 30% with every year above the age of 34
years [23–24]. In the current study, we have shown similar results:
compared with women aged 20–24 years, the risk of HDP was 1.8
times higher in those aged 35–39 years and 2.4 times higher in
those aged 40 years and older (Table 1 and Table S3 in File S1). It
has been frequently reported that HDP commonly occurs in the
first delivery [25–26].
There is a close relationship between HDP and pre-pregnancy
BMI, including the increased risk of HDP in women with obesity
during pregnancy [19], [27–29]. Some studies suggest that each
increase of 5 to 7 kg/m2 in BMI doubles the risk of developing
preeclampsia [30–31]. Obese women were at a higher risk of
preeclampsia compared to those with a normal BMI [32]. Our
work confirms the association of body weight with risk of HDP:
obese women had the highest risk of HDP (Table 1 and Table S3
in File S1). In recent years, attention has been paid to the
relationship between the morbidity in HDP and the levels of
maternal education. Convincing evidence suggests that women
with a low level of education are more likely to develop HDP than
those who have received a higher level of education [33–34]. The
present study provides weak evidence in support of the impact of
education levels on the risk of HDP (Table S3 in File S1).
Epidemiological data indicate that HDP shows a trend towards
familial aggregation [35–36].The prevalence of HDP in women
who had two or more family members with HDP was 2 to 3 times
higher than that the general female population [19], [37]. High
blood pressure was an independent risk factor for preeclampsia
[38]. SBP at first antenatal visit was positively associated with the
risk of preeclampsia; Women with SBP of $130 mmHg had a
relative risk of 3.6 compared to those with pre-pregnancy SBP of
,110 mmHg [39]. In a retrospective cohort study, Stamilio et al
found that a mean arterial pressure of .90 mmHg measured in
the first prenatal visit was associated with a high risk of severe
preeclampsia [40]. It has been suggested that blood pressure is an
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indicator of the degree of HDP [41–43]. Our work also suggests
that GDM is a risk factor for HDP. Similar findings have been
reported in several previous studies [44–45].
Conclusions
The pathogenesis mechanism behind of HDP remains to be
fully understood. It is difficult to make effective diagnosis and
treatment method that can be directed towards the pathogenesis of
the condition. The present report describes a large cohort
retrospective survey on HDP and has identified a number of risk
factors for the condition in the Chinese population. To our
knowledge, this is the largest epidemiological survey reported to
date and this work has provided comprehensive information about
the risk factors involved in HDP among the Chinese population.
Identification of these risk factors for HDP would be useful for
early diagnosis of HDP in a particular patient group that requires
clinical monitoring and appropriate treatment. In future studies, it
is critical to find effective interventions and preventions of HDP
which are particularly important to reduce maternal and perinatal
complications, and ensure both pregnant women and infants to be
healthy and safe.
Strengths and Limitations
As a multicenter clinical epidemiological research, we had the
large number of 112386 patients came from thirty-eight hospitals
of 14 provinces and regions over the Chinese country, while most
other studies present a smaller number of patients derived from
one hospital or from a local area. As a retrospective study, part of
the clinical data was not completed, which undetected and
deviations can exist. Some data such as income, personality, diet,
drug abuse, etc. cannot be obtained from cases, so it can not
represent all of the risk factors.
Supporting Information
File S1 Supporting tables. Table S1, Assignment of
potential risk factors for HDP. Table S2, Collinearity diagnostics
of independent variables. Table S3, Multivariate logistic analysis
of 18 risk factors for HDP. Table S4, Differences in outcomes
between HDP.
(DOC)
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